Company Filing History:
3 out of 1,209 
3 out of 2,963 
2 out of 517 
Years Active: 2021-2025
Title: Inventor Vikram R. Juneja: Innovating Cancer Research with Novel Antibodies
Introduction
Vikram R. Juneja is a notable inventor based in Boston, MA, recognized for his significant contributions to the field of cancer research. With a total of three patents to his name, Juneja's work primarily focuses on the development of advanced methods and agents for modulating programmed death 1 (PD-1) signaling, a crucial area in cancer therapy.
Latest Patents
Juneja's latest patents showcase innovative methodologies related to PD-1 signaling. One of his key patents describes a method of assessing the efficacy of a test agent for modulating PD-1 signaling by utilizing anti-phosphotyrosinylated PD-1 monoclonal antibodies. This invention highlights his discovery of monoclonal and polyclonal antibodies that specifically bind to phosphorylated PD-1. The implications of this are significant, as it opens avenues for diagnostic, prognostic, and therapeutic applications in cancer treatment.
Another relevant patent elaborates on anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, establishing methods of making and utilizing these antibodies. This research emphasizes the potential for these antibodies to play a substantial role in advancing cancer therapeutic strategies.
Career Highlights
Vikram Juneja has built a commendable career through his affiliations with prestigious institutions such as Harvard College and the Dana-Farber Cancer Institute Inc. His research has paved the way for understanding complex cancer mechanisms and designing targeted therapies.
Collaborations
Throughout his career, Juneja has collaborated with esteemed colleagues, including Gordon James Freeman and Arlene Helen Sharpe. These partnerships exemplify the importance of collaborative efforts in advancing scientific research and innovation.
Conclusion
Vikram R. Juneja stands out in the realm of cancer research through his innovative contributions and patented technologies. His work continues to inspire advancements in therapeutic approaches for cancer treatment, showcasing the potential of scientific innovation to make significant impacts on human health.